ENO2 and laryngotracheoesophageal cleft: A valuable study identified serum miR-128-3p and miR-33a-5p, downregulated in LC, singularly or in combination, as accurately diagnosing all-stage and early-stage LC (AUC: 0.93 and 0.93 for miR-128-3p, 0.87 and 0.85 for miR-33a-5p, 0.95 and 0.96 for their combination) with better performances than the more common CYFR21-1, NSE, and CA-72-4 (AUC: 0.59, 0.62, and 0.52) [87].